BRPI0814666A2 - composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida - Google Patents

composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida

Info

Publication number: BRPI0814666A2
Authority: BR; Brazil
Prior art keywords: dosage form; solid dosage; formulation; preparing; pharmaceutical composition
Prior art date: 2007-07-23

Application number

BRPI0814666A

Other languages

English (en)

Inventor

Iliopoulou Athina

Matsingou Christina

Karavas Evangelos

Koutris Makis

Samara Vicky

Original Assignee

Pharmathen Sa

Recordati Ireland Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-23

Filing date

2008-07-23

Publication date

2017-05-09

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0814666(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-07-23 Application filed by Pharmathen Sa, Recordati Ireland Ltd filed Critical Pharmathen Sa

2017-05-09 Publication of BRPI0814666A2 publication Critical patent/BRPI0814666A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Hydrogenated Pyridines (AREA)

BRPI0814666A 2007-07-23 2008-07-23 composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida BRPI0814666A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/EP2007/006517 WO2009012791A1 (en)	2007-07-23	2007-07-23	Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
PCT/EP2008/059645 WO2009013306A1 (en)	2007-07-23	2008-07-23	Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (1)

Publication Number	Publication Date
BRPI0814666A2 true BRPI0814666A2 (pt)	2017-05-09

Family

ID=39223083

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BRPI0721883-4A2A BRPI0721883A2 (pt)	2007-07-23	2007-07-23	Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma
BRPI0814666A BRPI0814666A2 (pt)	2007-07-23	2008-07-23	composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BRPI0721883-4A2A BRPI0721883A2 (pt)	2007-07-23	2007-07-23	Composição farmacêutica contendo antagonista de canal de cálcio de dihidropiridina e processo para a preparação da mesma

Country Status (20)

Country	Link
EP (2)	EP2180883B1 (pt)
JP (2)	JP5769963B2 (pt)
KR (2)	KR101632079B1 (pt)
CN (3)	CN101784260A (pt)
AU (2)	AU2007356942B2 (pt)
BR (2)	BRPI0721883A2 (pt)
CA (2)	CA2691752C (pt)
CO (1)	CO6290639A2 (pt)
CR (1)	CR11285A (pt)
EA (2)	EA021645B1 (pt)
EC (1)	ECSP109984A (pt)
ES (2)	ES2622495T3 (pt)
MA (1)	MA31684B1 (pt)
MX (2)	MX2010000856A (pt)
MY (1)	MY153857A (pt)
NZ (2)	NZ582648A (pt)
TN (2)	TN2010000011A1 (pt)
UA (2)	UA97161C2 (pt)
WO (2)	WO2009012791A1 (pt)
ZA (2)	ZA201000586B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008063888A2 (en)	2006-11-22	2008-05-29	Plexxikon, Inc.	Compounds modulating c-fms and/or c-kit activity and uses therefor
AU2008276063B2 (en)	2007-07-17	2013-11-28	Plexxikon Inc.	Compounds and methods for kinase modulation, and indications therefor
MX2010000856A (es) *	2007-07-23	2010-04-30	Pharmathen Sa	Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.
EP2414356B1 (en) *	2009-04-03	2015-09-02	F.Hoffmann-La Roche Ag	Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
US8329724B2 (en)	2009-08-03	2012-12-11	Hoffmann-La Roche Inc.	Process for the manufacture of pharmaceutically active compounds
MX2012005284A (es)	2009-11-06	2012-06-28	Plexxikon Inc	Compuestos y metodos para la modulacion de cinasas. e indicaciones para ello.
EA028821B9 (ru)	2011-02-07	2018-10-31	Плексксикон, Инк.	Соединения и способы для модуляции киназ, а также показания к их применению
AR085279A1 (es)	2011-02-21	2013-09-18	Plexxikon Inc	Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
CN113842362A (zh)	2012-11-14	2021-12-28	格雷斯公司	含有生物活性材料与无序无机氧化物的组合物
GR1008554B (el) *	2014-06-12	2015-09-03	ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ,	Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) *	2014-06-20	2014-10-01	湖南天地恒一制药有限公司	一种包含乐卡地平的药物组合物
CN105168165B (zh) *	2015-08-28	2018-06-26	江苏福邦药业有限公司	一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) *	2016-07-01	2018-01-04	Общество С Ограниченной Ответственностью "Гиостин"	Средство в виде капсулы для лечения заболеваний суставов
CN114533686B (zh) *	2022-02-15	2023-10-20	湖南普道医药技术有限公司	一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) *	2022-09-21	2024-03-28	주식회사 종근당	사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3720757A1 (de) *	1987-06-24	1989-01-05	Bayer Ag	Dhp-manteltablette
US5209933A (en) *	1990-01-10	1993-05-11	Syntex (U.S.A.) Inc.	Long acting calcium channel blocker composition
GB9025251D0 (en) *	1990-11-20	1991-01-02	Solomon Montague C	Nifedipine dosage forms
BR9903490A (pt) *	1998-12-15	2000-09-26	Oscar Gold	Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) *	1999-09-20	2001-03-29	Bayer Ag	Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) *	2003-01-31	2004-09-23	Glenmark Pharmaceuticals Ltd.	Controlled release modifying complex and pharmaceutical compositions thereof
CA2547657A1 (en) *	2003-12-01	2005-06-16	Lifecycle Pharma A/S	Pharmaceutical compositions comprising lercanidipine
CN1901888A (zh) *	2003-12-01	2007-01-24	生命周斯药物公司	包含乐卡地平的药物组合物
AU2007291509B2 (en) *	2006-08-30	2013-05-02	Jagotec Ag	Controlled release oral dosage formulations comprising a core and one or more barrier layers
EP2101771A2 (en) *	2006-12-06	2009-09-23	Torrent Pharmaceuticals Ltd	Stable lercanidipine formulation
MX2010000856A (es) *	2007-07-23	2010-04-30	Pharmathen Sa	Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma.

2007
- 2007-07-23 MX MX2010000856A patent/MX2010000856A/es active IP Right Grant
- 2007-07-23 BR BRPI0721883-4A2A patent/BRPI0721883A2/pt not_active IP Right Cessation
- 2007-07-23 NZ NZ582648A patent/NZ582648A/en unknown
- 2007-07-23 EA EA201070160A patent/EA021645B1/ru not_active IP Right Cessation
- 2007-07-23 ES ES07786262.1T patent/ES2622495T3/es active Active
- 2007-07-23 AU AU2007356942A patent/AU2007356942B2/en active Active
- 2007-07-23 KR KR1020107001425A patent/KR101632079B1/ko active IP Right Grant
- 2007-07-23 CN CN200780100025A patent/CN101784260A/zh active Pending
- 2007-07-23 EP EP07786262.1A patent/EP2180883B1/en active Active
- 2007-07-23 UA UAA201001781A patent/UA97161C2/ru unknown
- 2007-07-23 WO PCT/EP2007/006517 patent/WO2009012791A1/en active Application Filing
- 2007-07-23 CA CA2691752A patent/CA2691752C/en active Active
- 2007-07-23 JP JP2010517273A patent/JP5769963B2/ja not_active Expired - Fee Related
2008
- 2008-07-23 CN CN200880100075A patent/CN101801347A/zh active Pending
- 2008-07-23 JP JP2010517393A patent/JP2010534220A/ja active Pending
- 2008-07-23 MX MX2010000801A patent/MX2010000801A/es active IP Right Grant
- 2008-07-23 EA EA201000220A patent/EA019614B1/ru unknown
- 2008-07-23 WO PCT/EP2008/059645 patent/WO2009013306A1/en active Application Filing
- 2008-07-23 EP EP20080775312 patent/EP2170295B1/en active Active
- 2008-07-23 KR KR1020107002430A patent/KR101512404B1/ko active IP Right Grant
- 2008-07-23 MY MYPI2010000318A patent/MY153857A/en unknown
- 2008-07-23 CA CA2693233A patent/CA2693233A1/en not_active Abandoned
- 2008-07-23 BR BRPI0814666A patent/BRPI0814666A2/pt not_active IP Right Cessation
- 2008-07-23 CN CN201410243247.6A patent/CN103976968A/zh active Pending
- 2008-07-23 ES ES08775312.5T patent/ES2537063T3/es active Active
- 2008-07-23 UA UAA201000447A patent/UA99136C2/ru unknown
- 2008-07-23 NZ NZ582690A patent/NZ582690A/en not_active IP Right Cessation
- 2008-07-23 AU AU2008280106A patent/AU2008280106B9/en not_active Ceased
2010
- 2010-01-08 TN TNP2010000011A patent/TN2010000011A1/fr unknown
- 2010-01-13 TN TNP2010000022A patent/TN2010000022A1/fr unknown
- 2010-01-20 CO CO10005281A patent/CO6290639A2/es not_active Application Discontinuation
- 2010-01-26 ZA ZA2010/00586A patent/ZA201000586B/en unknown
- 2010-02-17 MA MA32628A patent/MA31684B1/fr unknown
- 2010-02-18 ZA ZA2010/01176A patent/ZA201001176B/en unknown
- 2010-02-19 CR CR11285A patent/CR11285A/es unknown
- 2010-02-23 EC EC2010009984A patent/ECSP109984A/es unknown

Also Published As

Publication number	Publication date
EP2180883A1 (en)	2010-05-05
AU2007356942A1 (en)	2009-01-29
EP2170295A1 (en)	2010-04-07
JP5769963B2 (ja)	2015-08-26
ES2537063T3 (es)	2015-06-02
NZ582690A (en)	2011-12-22
ZA201000586B (en)	2011-03-30
EA021645B1 (ru)	2015-08-31
NZ582648A (en)	2012-06-29
CA2693233A1 (en)	2009-01-29
EA201070160A1 (ru)	2010-06-30
KR20100047848A (ko)	2010-05-10
CN101801347A (zh)	2010-08-11
AU2007356942B2 (en)	2011-12-15
CN103976968A (zh)	2014-08-13
MA31684B1 (fr)	2010-09-01
UA99136C2 (ru)	2012-07-25
WO2009013306A1 (en)	2009-01-29
AU2008280106B2 (en)	2014-03-20
KR101632079B1 (ko)	2016-06-20
ZA201001176B (en)	2010-11-24
KR20100045456A (ko)	2010-05-03
AU2008280106B9 (en)	2014-08-07
TN2010000011A1 (en)	2011-09-26
ECSP109984A (es)	2010-04-30
EA019614B1 (ru)	2014-05-30
ES2622495T3 (es)	2017-07-06
EP2180883B1 (en)	2017-01-11
CR11285A (es)	2010-04-27
JP2010534211A (ja)	2010-11-04
AU2008280106A2 (en)	2010-02-25
WO2009012791A1 (en)	2009-01-29
JP2010534220A (ja)	2010-11-04
MX2010000801A (es)	2010-07-05
EA201000220A1 (ru)	2010-08-30
EP2170295B1 (en)	2015-04-22
MY153857A (en)	2015-03-31
CA2691752C (en)	2016-01-26
KR101512404B1 (ko)	2015-04-21
TN2010000022A1 (en)	2011-09-26
AU2008280106A1 (en)	2009-01-29
UA97161C2 (ru)	2012-01-10
CA2691752A1 (en)	2009-01-29
MX2010000856A (es)	2010-04-30
CN101784260A (zh)	2010-07-21
BRPI0721883A2 (pt)	2014-02-18
CO6290639A2 (es)	2011-06-20

Similar Documents

Publication	Publication Date	Title
BRPI0814666A2 (pt)	2017-05-09	composição farmacêutica para a administração oral, uso de uma formulação. processo para a preparação de uma forma de dosagem sólida, e, forma de dosagem sólida
BRPI0818680A2 (pt)	2017-05-02	composição farmacêutica, preparação farmacêutica, e método para preparar um forma de dosagem oral farmacêutica
BRPI0816320A2 (pt)	2015-03-24	Composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto de combinação, e, processos para a preparação deu um composto, de uma formulação farmacêutica, e de um produto de combinação
BR112012003280A2 (pt)	2017-05-23	composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
BRPI0816553A2 (pt)	2017-07-18	"composto, composição farmcêutica, uso de uma composição, uso de um composto, e, processo para a preparação de um composto"
BRPI0905717A2 (pt)	2015-07-14	Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0917705A2 (pt)	2016-02-16	composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto
BRPI0821115A2 (pt)	2015-06-16	Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0812851A2 (pt)	2014-09-30	Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BRPI1006162A2 (pt)	2019-09-24	"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
IL233677A (en)	2016-11-30	Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
BRPI0915084A2 (pt)	2015-10-27	composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, métodos para a profilaxia ou tratamento de um estado de doença ou uma condição e de câncer
IL212573A (en)	2015-01-29	Aryl Methyl Benzokinazulinone Compounds
BRPI1014865A2 (pt)	2016-05-03	"composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica"
CL2007002018A1 (es)	2008-05-09	Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular.
BR112012016398A2 (pt)	2018-08-21	Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa
BRPI0808034A2 (pt)	2014-06-17	Método para produzir hidrocloreto de prasugrel, hidrocloreto de prasugrel, composição farmacêutica, e, uso de um hidrocloreto de prasugrel.
IL208203A (en)	2016-06-30	Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
BRPI0912539A2 (pt)	2015-10-13	composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
BRPI0922174A2 (pt)	2015-12-29	preparação farmacêutica, uso de uma preparação, e, método para preparar uma preparação farmacêutica
BRPI1009392A2 (pt)	2016-03-08	"formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BRPI0719880A2 (pt)	2014-06-10	Forma de dosagem sólida farmacêutica para administração oral e método para preparar a mesma.
CL2013001885A1 (es)	2014-03-28	Compuestos derivados de morfina, antagonistas del receptor ipiode periferico; composicion farmaceutica; formulacion oral; y uso para reducir los efectos colaterales de la terapia opioide (div. sol. 905-08).

Legal Events

Date	Code	Title	Description
2018-03-06	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-22	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]
2018-10-16	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2472 DE 22-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2021-07-13	B350	Update of information on the portal [chapter 15.35 patent gazette]